Licensed clinicians. THC-free, pharmacy-compounded cannabidiol. LegitScript Certified fulfillment. All live in weeks, under your brand — powered by CareValidate and Kazmira Therapeutics.
of active CBD users take under 50mg/day — a fraction of the studied dose
daily dose range examined in published clinical research
of today's retail hemp products fall outside the new federal definition after Dec 11, 2026
Congress closed the intoxicating-hemp loophole this fall. Synthetic cannabinoids lose federal hemp status on November 12, 2026; a new 0.4mg total-THC-per-container standard takes effect for the rest of the hemp category on December 11, 2026. Industry estimates put roughly 95% of hemp-derived cannabinoid products sold today outside the new federal definition. Payment processors and ad platforms are already pulling accounts ahead of enforcement.
CareValidate and Kazmira do all of that for you — a licensed clinician network, a LegitScript Certified compounding pharmacy, and a compliant prescription pathway your existing customers can move into, live before the deadline hits.
Whether you're an existing hemp/CBD storefront or launching fresh, tell us your customer base and current footprint.
Pre-vetted clinicians and Kazmira's LegitScript Certified pharmacy are activated under your program — no recruiting, no credentialing.
Patients are evaluated and, when appropriate, prescribed THC-free cannabidiol — compounded and shipped by Kazmira Pharmacy, under your storefront's brand.
Content pre-approval, compliance monitoring, and fulfillment run in the background so you can focus on your customers.
“The calls have already started. Operators who built real brands and real customer lists in the hemp space are being told by their payment processors that they have weeks, not years.”
Beyond payment processing, legal counsel is flagging broader exposure as the reclassification lands: product-liability policies written for a legal product now covering something federally reclassified mid-inventory, cargo and transit coverage gaps for shipments reclassified in transit, landlord and supplier contract disputes, e-commerce delistings, and loan or investor complications tied to affected inventory.
Source: Wilson Elser, “The Great Hemp Reset: How the Federal Ban on Intoxicating Hemp Products Will Reshape Risk and Coverage”
The demand your customers built isn't going away — it just can't be served over the counter anymore. The prescription pathway is regulated under pharmacy law, not the hemp definition, so it isn't touched by either deadline.
You keep your storefront, your brand, and your existing customer list. CareValidate and Kazmira supply the clinical network, LegitScript Certified pharmacy, and compliance layer underneath it — API-first, so it fits alongside the systems you already run.
LegitScript Certified pharmacy fulfillment (Kazmira Pharmacy)
Credentialed clinician network, licensed to prescribe THC-free cannabidiol
Pharmaceutical-grade, THC-free cannabidiol API — purified, third-party tested, made in Watkins, Colorado
Prescription compounded to the patient's exact dose, shipped to their door
Kazmira content pre-approval on every asset that names the medication
White-label patient support
Analytics and performance monitoring
API-first integration with your existing storefront, EHR, and fulfillment stack
Kazmira Pharmacy — the nation's first 503A compounding pharmacy specializing in pure, THC-free prescription CBD.
Kazmira Pharmacy holds LegitScript Healthcare Merchant Certification — no retail CBD brand can qualify for it.
The first vertically integrated cannabinoid company in the U.S. — API manufacturing, pharmacy, and telehealth under one roof.
Kazmira developed the method to remove every detectable trace of THC from cannabidiol at scale.
Pharmaceutical-grade API manufactured and third-party tested in Watkins, Colorado.
Reported by Forbes, Denver7, MedCity News, the Denver Gazette, MediaPost, and MDLinx.
